Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2021 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2021.9041
Abstract: Importance Patient-reported outcomes in the treatment of opioid dependence may differ between subcutaneously administered depot buprenorphine and daily sublingual buprenorphine. Objective To compare patient satisfaction between depot buprenorphine and sublingual buprenorphine in adult outpatients with… read more here.
Keywords: trial; treatment; sublingual buprenorphine; buprenorphine ... See more keywords
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings.
Sign Up to like & getrecommendations! Published in 2021 at "Addiction"
DOI: 10.1111/add.15627
Abstract: BACKGROUND AND AIMS Opioid agonist treatment is effective but resource intensive to administer safely in custodial settings, leading to significant under-treatment of opioid dependence in these settings worldwide. This study assessed the safety of subcutaneous… read more here.
Keywords: treatment; depot buprenorphine; treatment opioid; custodial settings ... See more keywords
Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences
Sign Up to like & getrecommendations! Published in 2019 at "Drug and Alcohol Review"
DOI: 10.1111/dar.12939
Abstract: Abstract Introduction and Aims There has been significant recent investment in new medications for opioid use disorder, including buprenorphine depot injections. Patients and professionals need good quality, independent information on medications to help them make… read more here.
Keywords: information; treatment; opioid use; buprenorphine ... See more keywords
Exploring patient experience and satisfaction with depot buprenorphine formulations: A mixed-methods study.
Sign Up to like & getrecommendations! Published in 2023 at "Drug and alcohol review"
DOI: 10.1111/dar.13616
Abstract: INTRODUCTION The introduction of depot buprenorphine for the treatment of opioid dependence allows for reduced dosing frequency compared with conventional treatments, such as oral methadone and sublingual buprenorphine-naloxone. Reduced dosing frequency is perceived to reduce… read more here.
Keywords: mixed methods; depot buprenorphine; buprenorphine; satisfaction ... See more keywords